Drugs taken by millions in the US may cause sexual behavior ‘Devi’ including pedophilia – but patients say they were not warned by doctors

A class of medicines commonly used to treat movement disorders such as Parkinson’s disease and anxious foot syndrome is pushing people into dangerous sexual behavior.

Patients receiving dopamine agonists say the drugs have caused uncontrollable impulses, including ignition, sex dependence and even pedophilia – letting them fight with feelings of shame and confusion.

Reports reviewed by the BBC suggest that the GSK drug manufacturer has known about the risk of so -called “Deviant” sexual behavior since 2003, however patients claim that their doctors continue to fail to warn them of these potentially destructive side effects.

Dopamine agonists imitate dopamine, a major brain chemical that controls movement and is activated by pleasure. However, these medicines can overestimate feelings of pleasure as they deafen the brain’s ability to know the consequences of our actions.

This can lead to impulse control disorders, with studies showing 13% to 24% of patients in dopamine agonists develop them.

While a warning of these dangerous behaviors is ranked along common side effects such as nausea and insomnia, research suggests that they often go unnoticed or diagnosed.

In the US, the American Academy of Sleep Medicine recommends that medicines be used only for short -term treatment, such as the care of the last life.

A 2003 report by GSK described two cases of deviant sexual behavior among men who were described by Dopamine aggregate for Parkinson’s disease.

In one, a 63-year-old-man sexually attacked a seven-year-old girl. The report said that the perpetrator’s lust had increased significantly from the beginning of his treatment and “his problem was then resolved” as his dose decreased.

At least 20 women described dopamine agonists for anxious foot syndrome told the BBC that medicines destroyed their lives. Many said they had not been warned of serious side effects and had no idea what was causing their messy behavior.

A woman, Claire, confessed how she began to leave her home in the early hours of the morning to seek sex. About a year after the ropinirol began, which had initially relieved its RLS symptoms, it Begal experiencing overwhelming and unprecedented sexual demands.

Wearing a top and jacket, she would regularly light her chest in any man she could, despite having a partner.

“It remains an element in your head that knows what you are doing is wrong, but it affects you to the point that you don’t know you are doing it,” she told the BBC.

Claire said it took years to linking these requests to her medicines – and they disappeared almost immediately when she stopped taking her. Now she feels “shame” and is “fascinated” in dangerous situations in which Helf introduced.

In many cases, women told the BBC that their doctors failed to appreciate the impact of medicines on their bodies over time.

Sarah, who begins to take a different dopamine agonist in her 50s, said her previously low sex car grew at the point where she became she became fully dependent. She began selling interiors and clear videos online, organizing phone sex with strangers and making bargaining – collecting $ 30,000 in debt.

To cope with the effects, it turned to self-medication, using opioids to relieve pain and sleep pills. After all, Sarah ended up in rehabilitation, but this led to the loss of the driver’s license and her work.

“I turned to things that were not healthy – I know the behavior was not me, but I couldn’t control it,” she told the BBC.

A classroom action lawsuit was raised against GSK in 2011 by the four patients of Parkinson’s disease who claimed that Ropinirole led to gambling debts and broken relationships.

They also argued that despite studies linking the drug with such behavior that in 2000, the GSK had failed to include warnings in its product literature by March 2007. The case was resolved, but the GSK denied responsibility.

In one state, the GSK told the BBC that Ropinirole had been described for more than 17 million treatments and underwent “extensive clinical evidence”. She added that the drug had proven to be effective and had a “characterized security profile”.

“As with all the medicines, [it] There are possible side effects and these are clearly stated in the information information, ”he said.

In response to her 2003 research that had found a link to “Deviant” sexual behavior, GSK told the BBC that this was shared with health authorities and informed updates in the information description – which now lists the effects

GSK did not respond immediately to the posting request for comment.